ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 161 filers reported holding ANTARES PHARMA INC in Q4 2019. The put-call ratio across all filers is 5.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $388,496,000 | -3.0% | 94,755 | -15.6% | 0.00% | 0.0% |
| Q4 2021 | $400,597,000 | +271.7% | 112,212 | +279.0% | 0.00% | – |
| Q3 2021 | $107,769,000 | +282.0% | 29,607 | +357.5% | 0.00% | – |
| Q2 2021 | $28,214,000 | -68.3% | 6,471 | -70.2% | 0.00% | – |
| Q1 2021 | $89,117,000 | -30.6% | 21,683 | -32.7% | 0.00% | – |
| Q4 2020 | $128,490,000 | +22.8% | 32,203 | -16.9% | 0.00% | – |
| Q3 2020 | $104,625,000 | +435.4% | 38,750 | +445.3% | 0.00% | – |
| Q2 2020 | $19,542,000 | -97.5% | 7,106 | -97.8% | 0.00% | -100.0% |
| Q1 2020 | $767,227,000 | +761.4% | 325,096 | +1615.5% | 0.00% | – |
| Q4 2019 | $89,070,000 | +11.8% | 18,951 | -20.4% | 0.00% | – |
| Q3 2019 | $79,675,000 | +41.6% | 23,819 | +39.3% | 0.00% | – |
| Q2 2019 | $56,272,000 | -38.2% | 17,104 | -43.1% | 0.00% | – |
| Q1 2019 | $91,061,000 | +60607.3% | 30,053 | +54541.8% | 0.00% | – |
| Q4 2018 | $150,000 | -99.1% | 55 | -98.9% | 0.00% | – |
| Q3 2018 | $16,508,000 | +30.2% | 4,913 | 0.0% | 0.00% | – |
| Q2 2018 | $12,676,000 | -81.0% | 4,913 | -83.8% | 0.00% | – |
| Q1 2018 | $66,799,000 | +12.8% | 30,363 | +2.1% | 0.00% | – |
| Q4 2017 | $59,195,000 | +26.3% | 29,746 | +105.6% | 0.00% | – |
| Q3 2017 | $46,880,000 | -3.5% | 14,469 | -4.1% | 0.00% | – |
| Q2 2017 | $48,590,000 | +59156.1% | 15,090 | +51934.5% | 0.00% | – |
| Q1 2017 | $82,000 | +20.6% | 29 | 0.0% | 0.00% | – |
| Q4 2016 | $68,000 | +38.8% | 29 | 0.0% | 0.00% | – |
| Q3 2016 | $49,000 | +63.3% | 29 | 0.0% | 0.00% | – |
| Q2 2016 | $30,000 | -99.9% | 29 | -99.9% | 0.00% | – |
| Q4 2015 | $34,720,000 | -34.8% | 28,694 | -8.4% | 0.00% | – |
| Q3 2015 | $53,237,000 | +98.8% | 31,316 | +143.2% | 0.00% | – |
| Q2 2015 | $26,778,000 | +264.6% | 12,874 | +375.1% | 0.00% | – |
| Q1 2015 | $7,344,000 | -42.3% | 2,710 | -61.1% | 0.00% | – |
| Q3 2014 | $12,737,000 | +2432.2% | 6,960 | +3745.3% | 0.00% | – |
| Q1 2014 | $503,000 | -92.3% | 181 | -87.6% | 0.00% | – |
| Q4 2013 | $6,554,000 | -94.8% | 1,463 | -95.3% | 0.00% | – |
| Q3 2013 | $126,108,000 | -15.8% | 31,061 | -13.7% | 0.00% | – |
| Q2 2013 | $149,689,000 | – | 35,983 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |